injectable ghk cu peptide GHK-Cu Copper | Skin & Healing ghk cu peptide fda approved

Experimental research has suggested that BPC-157 may interact with nitric oxide signaling pathways and influence vascular growth factors that regulate angiogenesis

Delivered faster than expected

Clinical Weight Loss Results In a 12-week randomized clinical trial involving 300 obese adults, subjects receiving 1 mg daily of AOD-9604 lost an average of 2.6 kg compared to 0.8 kg in the placebo group

In topical application, studies use concentrations of 0.01-1% in cream or serum formulations (Pickart et al., BioMed Res Int 2015For subcutaneous injection (research), doses vary depending on the experimental model

This is the route where oral administration has the most biological plausibility because the peptide can act locally on gut epithelium without requiring high systemic absorption

For maintenance in chronic conditions, monthly injections are typical